VahatiCor Appoints Harry D. Rowland as CEO
VahatiCor, Inc. has appointed Harry D. Rowland, Ph.D., as its new Chief Executive Officer. Rowland brings experience from his previous role as CEO and President of Endotronix, where he led significant advancements in heart failure technology. He was instrumental in the development and commercialization of the Cordella™ Pulmonary Artery Sensor and Heart Failure System, and under his leadership, Endotronix raised over $150 million.
SANTA CLARA, Calif.–(BUSINESS WIRE)–VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer. Rowland previously served as Chief Executive Officer and President of Endotronix, where he led the development and commercialization of the Cordella™ Pulmonary Artery Sensor and Heart Failure System. Under his leadership, Endotronix raised over $150 millio